PLATELET-ACTIVATING-FACTOR (PAF) AND THE DEVELOPMENT OF CHRONIC SUBDURAL-HEMATOMA

被引:16
作者
HIRASIMA, Y [1 ]
ENDO, S [1 ]
KATO, R [1 ]
OHMORI, T [1 ]
NAGAHORI, T [1 ]
NISHIJIMA, M [1 ]
KARASAWA, K [1 ]
NOJIMA, S [1 ]
TAKAKU, A [1 ]
机构
[1] TEIKYO UNIV,FAC PHARMACEUT SCI,TOKYO 173,JAPAN
关键词
CHRONIC SUBDURAL HEMATOMA; HISTOCHEMISTRY; PAF-ACETYLHYDROLASE; PLATELET-ACTIVATING FACTOR;
D O I
10.1007/BF01400868
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Platelet activating factor (PAF) content and PAF-acetylhydrolase (PAFAH) activity were measured in the plasma and haematoma of 34 chronic subdural haematoma (CSH) patients. The plasma PAF level in patients with CSH was higher than that in healthy controls. Although there was no correlation between the plasma PAF levels and the interval between the onset of symptoms and the day of sampling, namely, the interval after bleeding, the haematoma PAF level gradually decreased according to the interval after the onset of symptoms. There was no difference between plasma PAFAH activity in patients with CSH and that in healthy controls, and haematoma enzyme activity gradually increased correlated with the interval between the onset of symptoms and surgery. In addition, the localization of PAF in haematoma capsules was histochemically determined. PAF was solely localized to the peri-sinusoidal vessels in the outer membrane of haematoma capsules. Based on these biochemical and histochemical studies, we speculated that PAF may play a role in the development of chronic subdural haematomas.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 25 条
[1]  
BERGSTROM M, 1977, J COMPUT ASSIST TOMO, V1, P445
[2]   PAF-ACETHER (PLATELET-ACTIVATING FACTOR) INCREASES MICROVASCULAR PERMEABILITY AND AFFECTS ENDOTHELIUM-GRANULOCYTE INTERACTION IN MICROVASCULAR BEDS [J].
BJORK, J ;
LINDBOM, L ;
GERDIN, B ;
SMEDEGARD, G ;
ARFORS, KE ;
BENVENISTE, J .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (03) :305-308
[3]   INACTIVATION OF 1-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE BY A PLASMA ACETYLHYDROLASE - HIGHER ACTIVITIES IN HYPERTENSIVE RATS [J].
BLANK, ML ;
HALL, MN ;
CRESS, EA ;
SNYDER, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 113 (02) :666-671
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
CAMUSSI G, 1981, IMMUNOLOGY, V42, P191
[7]   BIOSYNTHETIC LABELING OF PLATELET ACTIVATING FACTOR FROM RADIOACTIVE ACETATE BY STIMULATED PLATELETS [J].
CHAP, H ;
MAUCO, G ;
SIMON, MF ;
BENVENISTE, J ;
DOUSTEBLAZY, L .
NATURE, 1981, 289 (5795) :312-314
[8]   IMMUNOHISTOCHEMICAL LOCALIZATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE LINING WALL OF CHRONIC SUBDURAL-HEMATOMA [J].
FUJISAWA, H ;
ITO, H ;
SAITO, K ;
IKEDA, K ;
NITTA, H ;
YAMASHITA, J .
SURGICAL NEUROLOGY, 1991, 35 (06) :441-445
[9]  
HANAHAN DJ, 1985, METHOD BIOCHEM ANAL, P195
[10]   DETECTION OF PLATELET-ACTIVATING-FACTOR IN EXUDATES OF RATS WITH PHORBOL-MYRISTATE ACETATE-INDUCED PLEURISY [J].
HAYASHI, M ;
KIMURA, J ;
YAMAKI, K ;
SUWABE, Y ;
DOZEN, M ;
IMAI, Y ;
OHISHI, S .
THROMBOSIS RESEARCH, 1987, 48 (03) :299-310